Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Apoptosis regulator Bcl-2 mRNA is the messenger RNA transcript that encodes the B-cell lymphoma 2 (Bcl-2) protein, a critical outer mitochondrial membrane protein that acts as a key inhibitor of apoptosis. The Bcl-2 protein prevents programmed cell death by blocking the release of cytochrome c from the mitochondria, thereby promoting cell survival and contributing to chemotherapy resistance in various malignancies. Overexpression of Bcl-2 is a hallmark of many cancers, particularly hematological malignancies such as chronic lymphocytic leukemia (CLL), non-Hodgkin's lymphoma (NHL), and acute myeloid leukemia (AML), as well as solid tumors like melanoma and lung cancer. Targeting Bcl-2 at the pre-translational level using antisense oligonucleotides (ASOs) represents a therapeutic strategy to downregulate Bcl-2 protein expression and restore sensitivity to apoptotic stimuli. Investigational drugs such as oblimersen sodium (Genasense) and the liposomal formulation BP1002 are designed to hybridize specifically with Bcl-2 mRNA, leading to its degradation or translation inhibition. By reducing intracellular Bcl-2 protein levels, these therapies lower the threshold for cancer cells to undergo apoptosis, especially when combined with standard cytotoxic chemotherapies or other targeted agents.
Antisense oligonucleotide binding to the initiation codon region of Bcl-2 mRNA, leading to RNase H-mediated cleavage or translational block, thereby reducing Bcl-2 protein expression and promoting apoptosis
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Apoptosis regulator Bcl-2 mRNA (BCL2 mRNA).